Spinal cord stimulation (SCS) is a proven and effective treatment that has been used for more than 50 years to help countless people around the world manage their chronic pain and improve their quality of life.¹ Dozens of well-designed, replicable clinical trials have repeatedly demonstrated the statistically significant benefits that SCS offers to combat chronic pain, particularly where other therapies have failed to achieve pain relief consistent with normal activities of daily life. Additionally, SCS treatments have been reviewed and approved by regulatory bodies around the world, and these ongoing assessments continue to support its safety and efficacy.

Abbott does not publicly comment on specific patients or their care and we adhere to applicable standards governing regulatory reporting.

Abbott takes its commitment to scientific excellence very seriously and we understand that people around the world rely on our technology to address their chronic pain conditions. As part of this commitment, Abbott works diligently with regulatory agencies to ensure our products offer a favorable safety profile and meet stringent approval standards.

Published studies supporting the safety and efficacy of Abbott’s spinal cord stimulation devices are available in the public domain.

References
¹ Nahm F. S. (2020). From the torpedo fish to the spinal cord stimulator. The Korean journal of pain, 33(2), 97–98. https://doi.org/10.3344/kjp.2020.33.2.97